Javascript must be enabled to continue!
Prevalence and risk factors for subclinical atherosclerosis amongst adults living with HIV in University of Abuja Teaching Hospital, Gwagwalada
View through CrossRef
BackgroundSubclinical atherosclerosis characterizes cardiovascular diseases (CVD), and Human Immunodeficiency Virus (HIV) infection and antiretroviral therapy (ART) are identified risk factors for atherosclerosis. Meanwhile, data on HIV and atherosclerosis in Nigeria are limited.ObjectivesWe sought to estimate the prevalence of subclinical atherosclerosis and associated risk factors amongst adult persons living with HIV/AIDS (PLHIV) enrolled at University of Abuja Teaching Hospital, Gwagwalada, Abuja (UATH).MethodsThis was a cross-sectional study of 277 consecutively selected PLHIV ≥18 years enrolled for HIV care and treatment at UATH. Pretested structured questionnaire was used to collect data from consenting ART-experienced and ART-naïve patients on risk factors of atherosclerosis. Carotid intima media thickness (CIMT) ≥0.71 mm as measured by Doppler ultrasonography was used to identify patients with sub-clinical atherosclerosis. Two logistic regression models with (Model-A) and without (Model-B) traditional risk factors were fitted to identify risk factors of subclinical atherosclerosis.ResultsParticipants' mean age was 39.44 ± 10.71 years with female preponderance (64.26%). Overall prevalence of subclinical atherosclerosis was 43.32% (62.25% in ART-experienced). Model-A identified male sex [AOR 4.33(1.74–10.76), p = 0.002], advancing age [30–39 years AOR 5.95(1.31–26.96), p = 0.021]; ≥40 years AOR 19.51(4.30–88.56), p ≤ 0.001), advancing HIV infection [≥WHO stage II AOR 4.19(1.11–15.92), p = 0.035], hypercholesterolemia [AOR 3.88(1.47–10.25), p ≤ 0.001] and ≥5 year duration on ART [AOR 9.05(3.16–25.92), p ≤ 0.001] as risk factors of subclinical atherosclerosis. In Model-B (excluding traditional risk factors) on the other hand, advancing HIV infection [≥WHO stage II AOR 3.93(1.19–13.042), p = 0.025] and duration on ART [≥5 years AOR 11.43(4.62–28.29), p = 0.001] were found as risk factors of subclinical atherosclerosis.ConclusionSubclinical atherosclerosis was higher in ART-experienced patients, and this was irrespective of presence or absence of traditional risk factors. And advancing HIV disease and duration on ART were found as significant risk factors for subclinical atherosclerosis. We therefore recommend routine CVD risk screening in PLHIV.
Title: Prevalence and risk factors for subclinical atherosclerosis amongst adults living with HIV in University of Abuja Teaching Hospital, Gwagwalada
Description:
BackgroundSubclinical atherosclerosis characterizes cardiovascular diseases (CVD), and Human Immunodeficiency Virus (HIV) infection and antiretroviral therapy (ART) are identified risk factors for atherosclerosis.
Meanwhile, data on HIV and atherosclerosis in Nigeria are limited.
ObjectivesWe sought to estimate the prevalence of subclinical atherosclerosis and associated risk factors amongst adult persons living with HIV/AIDS (PLHIV) enrolled at University of Abuja Teaching Hospital, Gwagwalada, Abuja (UATH).
MethodsThis was a cross-sectional study of 277 consecutively selected PLHIV ≥18 years enrolled for HIV care and treatment at UATH.
Pretested structured questionnaire was used to collect data from consenting ART-experienced and ART-naïve patients on risk factors of atherosclerosis.
Carotid intima media thickness (CIMT) ≥0.
71 mm as measured by Doppler ultrasonography was used to identify patients with sub-clinical atherosclerosis.
Two logistic regression models with (Model-A) and without (Model-B) traditional risk factors were fitted to identify risk factors of subclinical atherosclerosis.
ResultsParticipants' mean age was 39.
44 ± 10.
71 years with female preponderance (64.
26%).
Overall prevalence of subclinical atherosclerosis was 43.
32% (62.
25% in ART-experienced).
Model-A identified male sex [AOR 4.
33(1.
74–10.
76), p = 0.
002], advancing age [30–39 years AOR 5.
95(1.
31–26.
96), p = 0.
021]; ≥40 years AOR 19.
51(4.
30–88.
56), p ≤ 0.
001), advancing HIV infection [≥WHO stage II AOR 4.
19(1.
11–15.
92), p = 0.
035], hypercholesterolemia [AOR 3.
88(1.
47–10.
25), p ≤ 0.
001] and ≥5 year duration on ART [AOR 9.
05(3.
16–25.
92), p ≤ 0.
001] as risk factors of subclinical atherosclerosis.
In Model-B (excluding traditional risk factors) on the other hand, advancing HIV infection [≥WHO stage II AOR 3.
93(1.
19–13.
042), p = 0.
025] and duration on ART [≥5 years AOR 11.
43(4.
62–28.
29), p = 0.
001] were found as risk factors of subclinical atherosclerosis.
ConclusionSubclinical atherosclerosis was higher in ART-experienced patients, and this was irrespective of presence or absence of traditional risk factors.
And advancing HIV disease and duration on ART were found as significant risk factors for subclinical atherosclerosis.
We therefore recommend routine CVD risk screening in PLHIV.
Related Results
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Background: The HIV pandemic has attracted unprecedented scale-up in resources to curb its escalation and manage those afflicted. Although evidence from developing countries sugges...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case–control study
Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case–control study
Abstract
Background
Cardiovascular diseases (CVD) are a major cause of death in people with AIDS. Factors contributing to atherosclerosis include...
Prevalence of Gastro-Intestinal Parasites in Clarias gariepinus Caught in the Gwagwalada River, Gwagwalada, Abuja, Nigeria
Prevalence of Gastro-Intestinal Parasites in Clarias gariepinus Caught in the Gwagwalada River, Gwagwalada, Abuja, Nigeria
This paper reports the prevalence of gastro-intestinal parasites in Clarias gariepinus caught in the Gwagwalada River, Abuja, north central Nigeria. Sixty specimens of wild catfish...
Stigma Kills
Stigma Kills
Stigma due to an HIV diagnosis is a well-known phenomenon and is a major barrier to accessing care.1Over the last forty years, HIV has been transformed from a fatal disease to a ma...


